Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00932477 · ClinicalTrials.gov registry record · NA
Safety and Tolerability of Artificial Tears in Dry Eye Subjects
A NA study, sponsored by Allergan.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
NCT00932477 is a NA study that has completed, run by Allergan. The registered enrollment target is 47 participants.
The verdict
NCT00932477, a NA study, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
Study Summary
The safety and tolerability of two new artificial tears will be compared to a currently-available artificial tear in subjects with dry eye. Each subject will receive all three products in a randomly assigned order. The subject will use one product at a time for a duration of one week before switching to the next assigned product.
Interventions
- DRUG Formulation 1: Carboxymethylcellulose Sodium, Glycerin and Polysorbate 80, based artificial tear
- DRUG Formulation 2: Carboxymethylcellulose Sodium, Glycerin and Polysorbate 80, based artificial tear
- DRUG Glycerin and Polysorbate 80 based artificial tear
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2009-08 |
| Est. Completion | 2009-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00932477
The ClinicalTrials.gov registry entry for NCT00932477 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Formulation 1: Carboxymethylcellulose Sodium, Glycerin and Polysorbate 80, based artificial tear is the first listed.
NCT00932477 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00932477 about?
NCT00932477 is a clinical study titled "Safety and Tolerability of Artificial Tears in Dry Eye Subjects". The safety and tolerability of two new artificial tears will be compared to a currently-available artificial tear in subjects with dry eye. Each subject will receive all three products in a randomly assigned order. The subject will use one product at a time for a duration of one week before switchin...
What is the current status of trial NCT00932477?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2009-08. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00932477?
The interventions under investigation include: Formulation 1: Carboxymethylcellulose Sodium, Glycerin and Polysorbate 80, based artificial tear (DRUG), Formulation 2: Carboxymethylcellulose Sodium, Glycerin and Polysorbate 80, based artificial tear (DRUG), Glycerin and Polysorbate 80 based artificial tear (DRUG).
Who is sponsoring clinical trial NCT00932477?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.